Israel’s BioLineRx has licensed its BL-8030 oral treatment for the Hepatitis C virus (HCV) to China’s Jiangsu Chia-tai Tianqing. Approximately 43 million Chinese suffer from Hepatitis C – a chronic and debilitating disease.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000851299&fid=1725
China to use Israeli Hepatitis Vaccine
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.